Application of the Continuous Scale Physical Functional Performance Test to People with Parkinson Disease

Schenkman, Margaret; Cutson, Toni M.; Kuchibhatla, Maggie; Scott, Burton L.; Cress, Elaine

doi:10.1097/01253086-200226030-00004

Cited by 13 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This test has been validated in PD patients. (10) Participants also completed section 2 of the UPDRS which is a clinician administered survey of 13 patient-reported activities of daily living including ratings of several daily activities (e.g. hand-writing, dressing), gait (e.g.…”

Section: Methodsmentioning

confidence: 99%

“…(8) This measure is reliable and valid, both for healthy individuals and those with a variety of disorders, including PD. (8-10) Furthermore, cross sectional data from a large sample of individuals from Hoehn and Yahr stages 1 to 3 indicate that the CS-PFP detects functional loss early in the disease and progressively worsens across stages of PD. (11)…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Determinants of Objectively Measured Physical Functional Performance in Early to Mid‐stage Parkinson Disease

Kluger

Brown

Aerts

et al. 2014

PM&R

Self Cite

View full text Add to dashboard Cite

Background Parkinson disease (PD) may lead to functional limitations through both motor and non-motor symptoms. While patients with advanced disease have well-documented and profound functional limitations, less is known about the determinants of function in early to mid-stage disease where interventions may be more likely to benefit and preserve function. Objective The objective of the current study was to identify motor, cognitive and gait determinants of physical functional performance in patients with early to mid-stage PD. Design Secondary analysis of cross-sectional baseline data from a randomized clinical trial of exercise. Setting Tertiary academic medical center. Participants 121 patients with early to mid-stage PD. Methods Our functional performance outcomes included: 1) the Continuous Scale Functional Performance Test (CS-PFP; primary outcome); 2) the timed up and go (TUG) tests; and Section 2 (Activities of Daily Living) of the Unified Parkinson's Disease Rating Scale (UPDRS). Explanatory variables included measures of disease severity, motor function, cognitive function, balance and gait. Step-wise linear regression models were used to determine correlations between explanatory variables and outcome measures. Results In our regression models the CS-PFP significantly correlated with walking endurance (six minute walk; r2 = 0.12, p < .0001), turning ability (360 degree turn; r2 = .03, p = .002), attention (brief test of attention; r2 = .01, p = .03), overall cognitive status (Mini-mental State Examination; r2 = .01, p = .04) and bradykinesia (timed tapping; r2 = .02, p = .02). The TUG significantly correlated with walking speed (5 meter walk; r2 = 0.33, p <.0001), stride length (r2 = 0.25, p <.0001), turning ability (360 turn r2 = .05, p = .0003) and attention (r2 = .016, p = .03). Section 2 of the UPDRS was significantly correlated with endurance (r2 = .09, p < .0001), turning ability (r2 = .03, p = .001) and attention (r2 = .01, p = .03). Conclusions Gait, motor and cognitive function all contribute to objectively measured global functional ability in mild to moderate PD. Subjectively measured functional activity outcomes may underestimate the impact of both motor and non-motor symptoms.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Determinants of Objectively Measured Physical Functional Performance in Early to Mid‐stage Parkinson Disease

Kluger

Brown

Aerts

et al. 2014

PM&R

Self Cite

View full text Add to dashboard Cite

show abstract

“…When the data from the PD group was compared to data from communitydwelling adults without disease, results suggested that, in fact, the mild PD group did have subtle deficits in functional abilities. Further, the subscores from the CS-PFP suggested that mildly involved PD subjects are most impaired in lower body strength, balance, and coordination, while upper body strength and flexibility and endurance are less impaired (Schenkman et al, 2002). This suggests that in the early stage of the disease, functional abilities are impaired.…”

Section: Functional Abilitiesmentioning

confidence: 98%

“…To evaluate this question, a group of individuals with PD who, according to their UPDRS and Northwestern University Disability Scale (NUDS) scores, were considered to be mild and have little or no functional impairments (i.e. Total UPDRS = 29.7, motor subsection = 15 and ADL subsection =11.4) participated in this study (Schenkman, Cutson, Kuchibhatla, Scott, & Cress, 2002). When the data from the PD group was compared to data from communitydwelling adults without disease, results suggested that, in fact, the mild PD group did have subtle deficits in functional abilities.…”

Section: Functional Abilitiesmentioning

confidence: 99%

Motor Deficits, Exercise, and Parkinson's Disease

Robichaud

Corcos²

2005

Quest

View full text Add to dashboard Cite

“…Overall physical functional capacity was determined using the CS-PFP 13,14. This test consists of 16 tasks, performed serially, as fast as is comfortably possible for the individual.…”

Section: Methodsmentioning

confidence: 99%

Profile Pd

Schenkman

McFann²,

Barón³

2010

Journal of Neurologic Physical Therapy

Self Cite

View full text Add to dashboard Cite

Background and Purpose Individuals with Parkinson disease (PD) experience a range of deficits of body systems and activities. A clinical test is needed that is reliable, valid, applicable to physical therapist practice, and appropriate for use in early and mid-stages of the disease. PROFILE PD is one such scale, consisting of 24 items that would typically be assessed during the physical therapist's examination and evaluation of individuals with PD. The purpose of this paper is to report on clinimetric properties of the PROFILE PD and to make the test available for use. Methods Inter-rater reliability was determined using the intra-class correlation coefficient (ICC). Construct validity was determined by comparing scores on the PROFILE PD with the gold standard (UPDRS) as well as scales of physical activity and participation. Construct validity and structure of the PROFILE PD were further examined using exploratory factor analysis (EFA) using Principal Component Analysis (PCA) with Promax rotation which allows a correlated factor structure. Results Inter-rater reliability was estimated as 0.97. Construct validity was demonstrated with the UPDRS (r = 0.86, p < 0.0001), Schwab & England Activities of Daily Living Scale (S&E) (r = -0.83, p < 0.0001), and Continuous Scale Physical Functional Performance test (CS-PFP) (r = -0.62, p < 0.0001). PCA demonstrated a that the test comprises a single scale. Conclusions The PROFILE PD is a reliable and valid scale that can be used to quantify alterations in body systems and activity of individuals in early and mid-stages of PD. Use of the scale can provide an overall summary of the impact of PD on body systems and activities.

show abstract

Application of the Continuous Scale Physical Functional Performance Test to People with Parkinson Disease

Cited by 13 publications

References 0 publications

Determinants of Objectively Measured Physical Functional Performance in Early to Mid‐stage Parkinson Disease

Determinants of Objectively Measured Physical Functional Performance in Early to Mid‐stage Parkinson Disease

Motor Deficits, Exercise, and Parkinson's Disease

Profile Pd

Contact Info

Product

Resources

About